[1]
“Evaluating Knowledge And Awareness Of SGLT-2 Inhibitors’ Use, Efficacy, Side Effects, And Cardiovascular And Renal Impacts Among Primary Healthcare Physicians In Makkah, Saudi Arabia”, Rev Diabet Stud, pp. 490–500, Jun. 2025, doi: 10.70082/rr96vh76.